Fig. 4From: Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerMorphology of LNCaP and C4-2 cells following CBX2 depletion (96 h post-siRNA treatment). Images are representative of multiple fields taken from three independent experiments (×20 for large image and ×40 for small image)Back to article page